Apieron

Apieron Inc. was founded with the mission to revolutionize asthma management through innovative medical technology. The company's core vision is to provide accurate, non-invasive solutions for monitoring respiratory health. Apieron specializes in developing and manufacturing devices that measure exhaled nitric oxide, a key biomarker for asthma. Their primary product is a non-invasive monitor designed to help patients and healthcare providers better manage asthma. Apieron targets a global market, aiming to improve the quality of life for asthma sufferers worldwide.

Notable figures associated with Apieron include industry experts in medical device development and respiratory health. The company has garnered attention from investors focused on healthcare innovations. Key achievements include the successful development and market introduction of their flagship non-invasive monitor, which has been well-received for its accuracy and ease of use. Apieron's impact is significant in the field of asthma management, offering a reliable tool for both patients and clinicians to monitor and manage the condition more effectively.